STOCK TITAN

CABOT CORP (CBT) SEC Filings, Jul-Sep 2025

CBT NYSE
Rhea-AI Summary

Lisa M. Dumont, VP, Controller & CAO of Cabot Corporation (CBT), acquired phantom stock units on 09/11/2025 representing dividends paid on phantom stock units under the company's Supplemental 401(k) Plan. The Form 4 reports these units are to be settled in common stock upon the reporting person's retirement or other termination of employment. The filing shows 547.9886 shares (underlying amount) associated with the reported transaction and lists an attributable price reference of $81.47. The Form was signed by an attorney-in-fact on 09/15/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Raffiq Nathoo, a Cabot Corporation director, reported an acquisition of 21.8029 phantom stock units on 09/11/2025 that represent dividends on units held under the company's Non-Employee Director's Deferral Plan. Those units convert 1-for-1 into common stock and are tracked as 21.8029 underlying shares at an indicated per-share value of $81.47. After this transaction the reporting person beneficially owns 3,969.1023 shares directly. The units will be settled either when Mr. Nathoo leaves the board or according to his distribution election, whichever occurs first.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Sean D. Keohane, President and CEO of Cabot Corporation (CBT), reported an acquisition of 241.6837 phantom stock units on 09/11/2025. The filing shows the phantom units have an attributed value of $81.47 per underlying share and correspond to 241.6837 shares of common stock. After the transaction, Mr. Keohane beneficially owns 43,997.1756 shares. The filing explains these units represent dividends paid on phantom stock units under the Corporation's Supplemental 401(k) Plan and will be settled upon the reporting person's retirement or termination of employment. The Form 4 was signed by Jennifer Lombardi under power of attorney on 09/15/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Sean D. Keohane, President and CEO and a director of Cabot Corporation (CBT), reported option exercises and open-market sales on 08/14/2025. He exercised two employee stock options totaling 114,436 shares (26,455 at $49.26 and 87,981 at $50.46) and sold 114,436 shares in multiple transactions at weighted average prices disclosed for each tranche, with sale prices in the reported ranges of $78.570 to $79.740. After these transactions he beneficially owned 361,518 shares directly and an additional 13,842.5928 shares indirectly through the company 401(k) plan trustee, for a combined disclosed position.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Cabot Corporation (CBT) notice reports a proposed sale of 114,436 common shares, with an aggregate market value of $9,072,097.22, to be sold on 08/14/2025 through Fidelity Brokerage Services (NYSE). The filing shows the shares were acquired by exercise of options originally granted on 03/21/2016 (26,455 shares) and 11/11/2016 (87,981 shares) and that payment will be in cash. The filer states no securities of the issuer were sold by the same person in the past three months and attests they are not aware of undisclosed material adverse information about the issuer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.67%
Tags
current report
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many CABOT (CBT) SEC filings are available on StockTitan?

StockTitan tracks 120 SEC filings for CABOT (CBT), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for CABOT (CBT)?

The most recent SEC filing for CABOT (CBT) was filed on September 15, 2025.